|

liposomal irinotecan Clinical Trials

8 actively recruiting trials across 4 locations

▼ -1 trial since July 2026

Also known as: (Onivyde®), Nal-IRI, New Neoadjuvant Treatment Approach, irinotecan liposome, nal-IRI

Pipeline

Phase 1: 1Phase 2: 4Phase 3: 1Phase 1/2: 1

Top Sponsors

  • University of Wisconsin, Madison1
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
  • St. Jude Children's Research Hospital1
  • Peking University People's Hospital1
  • Hebei Medical University Fourth Hospital1

Indications

  • Cancer8
  • Osteosarcoma Metastatic1
  • Rectal Cancer, Adenocarcinoma1
  • Metastatic Pancreatic Adenocarcinoma1
  • Metastatic Pancreatic Cancer1

Other4 trials

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Phase 1/2
Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
Phase 2
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
N/A
Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
Phase 2

Tucson, Arizona1 trial

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

University of Arizona Cancer Center - North Campus

Phase 3

Duarte, California1 trial

A Study of ASP3082 in Adults With Advanced Solid Tumors

City of Hope National Medical Center

Phase 1

Palo Alto, California1 trial

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Stanford University

Phase 2

Madison, Wisconsin1 trial

Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

University of Wisconsin Carbone Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.